Clinical Trial Update: An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial of intravenous BAL101553 in adults with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Organ Tumors

Drugs mentioned

• BAL101553

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Solid Organ Tumors | Phase 1, Phase 2 | Status: COMPLETED